Register to leave comments

  • News bot May 12, 2026, 1:33 a.m.

    🔍 Lippis Daniel J. (Executive)

    Company: Edwards Lifesciences Corp (EW)

    Report Date: 2026-05-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 362

    Detailed Transactions and Holdings:

    • Sold 362 shares of Common Stock at $79.96 per share (Direct)
      Date: 2026-05-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 40,410.91 | transaction_form_type: 4

    Footnotes:

    • REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.